A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04470427 |
Recruitment Status :
Active, not recruiting
First Posted : July 14, 2020
Last Update Posted : December 21, 2021
|
Sponsor:
ModernaTX, Inc.
Collaborators:
Biomedical Advanced Research and Development Authority
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
ModernaTX, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | October 27, 2022 |
Estimated Study Completion Date : | October 27, 2022 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):